Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome

There are no proven safe and effective therapies for children who develop life-threatening complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Convalescent plasma (CP) has demonstrated potential benefit in adults with SARS-CoV-2, but has theoretical risks.We present the fi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Blood Cancer
Main Authors: Diorio, Caroline, Anderson, Elizabeth M., McNerney, Kevin O., Goodwin, Eileen C., Chase, Julie C., Bolton, Marcus J., Arevalo, Claudia P., Weirick, Madison E., Gouma, Sigrid, Vella, Laura A., Henrickson, Sarah E., Chiotos, Kathleen, Fitzgerald, Julie C., Kilbaugh, Todd J., Odom John, Audrey R., Blatz, Allison M., Lambert, Michele P., Sullivan, Kathleen E., Tartaglione, Margaret R., Zambrano, Danielle, Martin, Meghan, Lee, Jessica H., Young, Pampee, Friedman, David, Sesok-Pizzini, Deborah A., Hensley, Scott E., Behrens, Edward M., Bassiri, Hamid, Teachey, David T.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7734626/
https://ncbi.nlm.nih.gov/pubmed/32885904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.28693
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados